January 26, 2017 (HealthDay News) Modified T cells from healthy donor allowed infants to reach remission, researchers report Two infants with B-cell acute lymphoblastic leukemia (ALL) are in remission after …
Universal CAR T-Cell Therapy Helped Treat ALL in Two Infants Read More
May 22, 2017 (Medical News Today) An antibody originally developed to study multiple sclerosis has been found to precisely target T cells that can kill cancer cells. Researchers at Brigham …
Antibody That Precisely Targets T Cells Discovered Read More
April 21, 2017 (Medical News Today) André Veillette and a team of researchers at the Institut de recherches cliniques de Montréal (IRCM) / Montreal Clinical Research Institute have discovered why …
Why Does Immunotherapy Work in Some Patients but not in Others? Read More
April 26, 2017 (Medical News Today) Cellular therapy hasn’t had much success in fighting solid tumors, partly because it’s been difficult to deliver anti-cancer T cells to the tumors. A …
Implanted scaffold with T cells rapidly shrinks tumors Read More
April 25, 2017 (Medical News Today) The researchers call their approach “minimalist nanovaccine.” It is a simple mixture of the tumor antigen (molecules that uniquely identify the cancer target) and …
Nanovaccine shows potential as immunotherapy for cancer Read More
February 10, 2017 (CURE e-magazine)
Genetically engineering immune cells to treat cancers took another step forward after promising results from the phase 1 trial of Axicabtagene ciloleucel (KTE-C19), a CAR T-cell therapy for patients with refractory diffuse large B-cell lymphoma (DLBCL).
CAR T-Cell Therapy Is Safe, Effective in Lymphoma Read More
April 5, 2017 (Medical News Today)
There has been slow progress in immunotherapy for solid cancers. However, a recent study using adoptive T cell transfer, had some success on ovarian cancer. In this mouse study, the engineered T cells significantly increased survival rates.
Ovarian cancer: Effective immunotherapy steps closer with new T cell study Read More